Annabidiol Corp.
ACBD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $10 | $2 | $75 |
| % Growth | -100% | 566.7% | -98% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $10 | $2 | $75 |
| % Margin | – | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $130 | $20 | $15 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $130 | $20 | $15 | $10 |
| Operating Income | -$130 | -$10 | -$14 | $65 |
| % Margin | – | -100.3% | -902.7% | 86.1% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$130 | -$10 | -$14 | $65 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$130 | -$10 | -$14 | $65 |
| % Margin | – | -100.3% | -902.3% | 86.1% |
| EPS | -0.003 | -0 | -0 | 0.002 |
| % Growth | -1,000% | 0% | -118.8% | – |
| EPS Diluted | -0.003 | -0 | -0 | 0.002 |
| Weighted Avg Shares Out | 39,990 | 39,969 | 39,950 | 39,950 |
| Weighted Avg Shares Out Dil | 39,990 | 39,969 | 39,950 | 39,950 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $168 | $228 | $237 |
| EBITDA | -$130 | $158 | -$14 | $65 |
| % Margin | – | 1,578.7% | -902.7% | 86.1% |